PanGen Biotech Inc (222110) - Total Liabilities

Latest as of September 2025: ₩2.74 Billion KRW ≈ $1.86 Million USD

Based on the latest financial reports, PanGen Biotech Inc (222110) has total liabilities worth ₩2.74 Billion KRW (≈ $1.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of PanGen Biotech Inc to see how much of total assets are deployed in long-term investments.

PanGen Biotech Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how PanGen Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see PanGen Biotech Inc total assets.

PanGen Biotech Inc Competitors by Total Liabilities

The table below lists competitors of PanGen Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Scan-D TWO:6195	Taiwan	NT$2.20 Billion
Indopoly Swakarsa Industry Tbk JK:IPOL	Indonesia	Rp198.53 Million
BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- F:BLH	Germany	€1.05 Billion
Omesti Bhd KLSE:9008	Malaysia	RM76.39 Million
Grove Collaborative Holdings, Inc. NYSE:GROV	USA	$43.69 Million
BlockchAIn Digital Infrastructure, Inc NYSE MKT:AIB	USA	$9.41 Million
Transcontinental Inc TO:TCL-B	Canada	CA$1.37 Billion
S P V I Public Company Limited BK:SPVI	Thailand	฿730.69 Million

Liability Composition Analysis (2014–2024)

This chart breaks down PanGen Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is PanGen Biotech Inc's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PanGen Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PanGen Biotech Inc (2014–2024)

The table below shows the annual total liabilities of PanGen Biotech Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.64 Billion ≈ $3.82 Million	-31.06%
2023-12-31	₩8.18 Billion ≈ $5.54 Million	+136.67%
2022-12-31	₩3.45 Billion ≈ $2.34 Million	-84.43%
2021-12-31	₩22.18 Billion ≈ $15.03 Million	+0.37%
2020-12-31	₩22.10 Billion ≈ $14.98 Million	+6.98%
2019-12-31	₩20.66 Billion ≈ $14.00 Million	+10.65%
2018-12-31	₩18.67 Billion ≈ $12.65 Million	+335.84%
2017-12-31	₩4.28 Billion ≈ $2.90 Million	+104.76%
2016-12-31	₩2.09 Billion ≈ $1.42 Million	-77.60%
2015-12-31	₩9.34 Billion ≈ $6.33 Million	+50.99%
2014-12-31	₩6.18 Billion ≈ $4.19 Million	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$43.71 Million

₩64.50 Billion KRW

Market Cap Rank

#22490 Global

#1449 in Korea

Share Price

₩4780.00

Change (1 day)

+0.21%

52-Week Range

₩4330.00 - ₩7340.00

All Time High

₩24450.00